IP Library Granted Patent US 11,819,591
Granted Patent B2
US 11,819,591 · App. 15/775,137 · Granted Nov 21, 2023

Iron-based alloy absorbable and implantable medical device for internal fixation

Inventors: Wenjiao Lin (Shenzhen, CN); Deyuan Zhang (Shenzhen, CN)
Assignee: Biotyx Medical (Shenzhen) Co., Ltd.
A61L31/148A61L17/10A61L31/022A61L31/06A61L31/10A61L31/128A61L27/042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,819,591
App. No.
15/775,137
Granted
Nov 21, 2023
Kind
B2
Abstract

An iron-based alloy absorbable and implantable medical device for internal fixation. A substrate includes an iron-based alloy and degradable polymer. The mass ratio of the iron-based alloy to the degradable polymer is between 1:4 and 4:1. The weight-average molecular weight of the degradable polymer is between 150000 to 3000000, and the polydispersity index thereof is between 1 and 6. The device further includes antioxidants. The iron-based alloy is used as a load-bearing framework or reinforcement phase of the device. By adjusting the mass ratio of the iron-based alloy to the degradable polymer and the combination mode thereof, the corrosion rate of the iron-based alloy in the late period of the implantation is accelerated, and the quantity of corrosion products poorly soluble in the iron-based alloy is reduced. Adding antioxidants to the device further reduces the quantity of the corrosion products poorly soluble in the iron-based alloy.

Claims (30)

1. An iron-based alloy absorbable and implantable medical device for internal fixation, comprising:

a substrate of the iron-based alloy absorbable and implantable medical device for internal fixation that comprises an iron-based alloy and a degradable polymer; and

a degradable adhesive;

wherein the substrate has a mass ratio of the iron-based alloy to the degradable polymer that is between 1:4 and 4:1;

wherein the degradable polymer has a weight-average molecular weight that is more than or equal to 150,000 and less than or equal to 3,000,000, and a polydispersity index that is more than or equal to 1 and less than or equal to 6; and

wherein the degradable adhesive is selected from the group consisting of a polyester hot melt adhesive, a polyamide hot melt adhesive, a starch, a cyclodextrin, and a lignin; or wherein the degradable adhesive is a copolymer of at least two monomers selected from the group of monomers that form the polyester hot melt adhesive, the polyamide hot melt adhesive, the starch, the cyclodextrin, and the lignin.

2. An iron-based alloy absorbable and implantable medical device for internal fixation, comprising:

a substrate of the iron-based alloy absorbable and implantable medical device for internal fixation that comprises an iron-based alloy and a degradable polymer; and

a degradable adhesive;

wherein the substrate has a mass ratio of the iron-based alloy to the degradable polymer that is between 1:4 and 1:1;

wherein the degradable polymer has a weight-average molecular weight that is more than or equal to 150,000 and less than or equal to 3,000,000, and a polydispersity index that is more than or equal to 1 and less than or equal to 6;

wherein the degradable adhesive is selected from the group consisting of a polyester hot melt adhesive, a polyamide hot melt adhesive, a starch, a cyclodextrin, and a lignin; or wherein the degradable adhesive is a copolymer of at least two monomers selected from the group of monomers that form the polyester hot melt adhesive, the polyamide hot melt adhesive, the starch, the cyclodextrin, and the lignin.

3. The iron-based alloy absorbable and implantable medical device for internal fixation according to claim 2 , further comprising an antioxidant which is selected from the group consisting of butyl hydroxy anisole, butylated hydroxytoluene, tertiary butylhydroquinone, propyl gallate, carotenoid, ubiquinone, glutathione, water-soluble polyphenol, tocopherol, sodium tripolyphosphate, sodium ascorbate, lipoic acid salt and ascorbic palmitate.

4. The iron-based alloy absorbable and implantable medical device for internal fixation according to claim 2 , wherein a structural relationship between the iron-based alloy and the degradable polymer is selected from the group consisting of:

the iron-based alloy is distributed in the degradable polymer in a form of a solid or hollow bristle shape, filament shape or rod shape, a stent or a mesh;

the iron-based alloy and the degradable polymer are respectively prepared into layers, and the iron-based alloy layer and the polymer layer are alternated with each other;

the iron-based alloy is stranded on a degradable polymer filament in the form of a filament; and

the iron-based alloy has a groove, a pore, a gap or a hollow inner cavity, and the groove, the pore, the gap or the hollow inner cavity is filled with the degradable polymer.

5. The iron-based alloy absorbable and implantable medical device for internal fixation according to claim 2 , wherein the degradable polymer comprises:

a degradable polyester,

a mixture of the degradable polyester and at least one of a degradable polyanhydride, a degradable polyamino acid and a degradable polyphosphate ester, or

a copolymer of at least one monomer forming the degradable polyester and at least one monomer forming the degradable polyanhydride, the degradable polyamino acid or the degradable polyphosphate ester.

6. The iron-based alloy absorbable and implantable medical device for internal fixation according to claim 5 , wherein:

the degradable polyester is selected from the group consisting of polylactic acid, polyglycolic acid, poly(ethylene succinate), polycaprolactone, polyhydroxyalkanoate, polyethylene glycol adipate, a polylactic acid-glycolic acid copolymer, a polyhydroxybutyrate-pentanoate copolymer, and copolymers thereof;

the degradable polyanhydride is selected from the group consisting of crosslinked polyanhydride, aromatic polyanhydride, fatty acid polyanhydride, heterocyclic polyanhydride, poly-acyl anhydride, polyamide anhydride, and phosphorus-containing polyanhydrides; and

the degradable polyamino acid is selected from the group consisting of polyglycine, poly-methionine, polythionine, and polyaspartic acid.

7. The iron-based alloy absorbable and implantable medical device for internal fixation according to claim 2 , further comprising a complexing agent; wherein the complexing agent comprises a monodentate ligand and/or a polydentate ligand; wherein the monodentate ligand contains a single coordination group; wherein the polydentate ligand contains at least two coordination groups, said at least two coordination groups contain a hydroxyl on polycyclic aromatic hydrocarbon, sulfhydryl, amido, a hetero aromatic group, nitroso, carbonyl, sulpho, a phosphate group or an organic phosphine group.

8. The iron-based alloy absorbable and implantable medical device for internal fixation according to claim 2 , wherein the iron-based alloy has a carbon content less than or equal to 2.11 weight percent.

9. The iron-based alloy absorbable and implantable medical device for internal fixation according to claim 2 , wherein the device is a bone screw or a suture.

10. The iron-based alloy absorbable and implantable medical device for internal fixation according to claim 2 , wherein the initial bending strength is 350 MPa to 600 MPa.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2021
From: LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD
To: BIOTYX MEDICAL (SHENZHEN) CO., LTD.
Reel/Frame 055535/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2018
From: LIN, WENJIAO; ZHANG, DEYUAN
To: LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD
Reel/Frame 045768/0476 →
Priority Claims (1)
CN 201511032175.1 · Dec 31, 2015 · national
Continuity (1)
Related Publication 20180326127A1 · Nov 15, 2018